Torben Nissen
Chief Executive Officer at Repertoire Immune Medicines, Inc.
Net worth: - $ as of 2023-12-30
Torben Nissen active positions
| Companies | Position | Start | End |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | - | - |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Chief Executive Officer | 2022-11-05 | - |
Career history of Torben Nissen
Former positions of Torben Nissen
| Companies | Position | Start | End |
|---|---|---|---|
| AXCA HEALPAR | Director/Board Member | 2022-10-09 | 2023-10-31 |
| Independent Dir/Board Member | 2022-10-09 | 2023-10-31 | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Director/Board Member | 2018-07-31 | 2021-11-30 |
| RUBIUS THERAPEUTICS | Director/Board Member | 2016-10-31 | 2018-07-31 |
| President | 2016-10-31 | 2019-07-23 | |
| PFIZER, INC. | Corporate Officer/Principal | 2013-12-31 | 2016-10-31 |
| Centers for Therapeutic Innovation | Director/Board Member | 2011-06-30 | 2013-12-31 |
| Chief Operating Officer | 2011-06-30 | 2013-12-31 | |
| ASCENDIS PHARMA A/S | Chief Operating Officer | 2009-06-21 | 2011-05-31 |
| NOVO NORDISK A/S | Corporate Officer/Principal | - | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Torben Nissen
| Technical University of Denmark | Doctorate Degree |
Statistics
International
| United States | 10 |
| Denmark | 4 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
Sectoral
| Health Technology | 8 |
| Commercial Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| AXCA HEALPAR | Health Technology |
| Private companies | 7 |
|---|---|
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
| Centers for Therapeutic Innovation | |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Torben Nissen
- Experience
